SIGA Technologies Inc

Financials

Total assets 149.83 M214.73 M195.04 M254.35 M244.34 M Total liabilities 20.04 M40.41 M24.88 M57.49 M28.53 M Total equity 129.79 M174.31 M170.16 M196.86 M215.8 M Total liabilities & shareholders' equities 149.83 M214.73 M195.04 M254.35 M244.34 M Total debt ————— Net debt —————

SIGA Technologies, Inc. is an American pharmaceutical company founded in 1995, based in New York City, which develops and sells pharmaceutical solutions for the antiviral treatment of smallpox, monkeypox, cowpox, and vaccinia complications.

SIGA

Financials

SIGA Technologies Inc

ニュース

Siga Technologies: As Market Waits For MPOXX Purchases, I Remain On The Sidelines (SIGA)

Tesla, Applovin among market cap stock movers on Friday

SIGA Technologies, Inc. 2025 Q3 - Results - Earnings Call Presentation (NASDAQ:SIGA) 2025-11-07

SIGA Technologies, Inc. (SIGA) Q3 2025 Earnings Call Transcript

SIGA Technologies, Inc. (SIGA) Q2 2025 Earnings Call Transcript

3 Healthcare Stocks Paying the Highest Dividends of 2025

Siga Technologies Inc. (SIGA) Stock Falls Amid Market Uptick: What Investors Need to Know

Siga Technologies Inc. (SIGA) Outpaces Stock Market Gains: What You Should Know

Siga Technologies Inc. (SIGA) Dips More Than Broader Market: What You Should Know

SIGA Technologies updates bylaws, stockholders vote

SIGA Technologies: Asymmetric Upside, If 2025 Goes Right (NASDAQ:SIGA)

SIGA Technologies, Inc. (SIGA) Q4 2024 Earnings Call Transcript